New Medicines for Severe Human Brain Diseases
Innovation is a core value of ABAXYS Therapeutics.
ABAXYS provides high innovation in the discovery of new medicines for orphan diseases with unmet medical needs. Our early programs ABXY-1 and ABX-1002 successfully advance into preclinical development. Both programs, entering into hit-to-lead, aim to deliver new medicines for the treatment of Epilepsy and Parkinson’s disease. They will strengthen ABAXYS’ efforts to cure human brain diseases.
